NaN
/
of
-Infinity
PayPal, credit cards. Download editable-PDF & invoice in 1 second!
YY/T 1206-2013 English PDF (YY/T1206-2013)
YY/T 1206-2013 English PDF (YY/T1206-2013)
Regular price
$150.00 USD
Regular price
Sale price
$150.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Delivery: 3 seconds. Download true-PDF + Invoice.
Get Quotation: Click YY/T 1206-2013 (Self-service in 1-minute)
Historical versions (Master-website): YY/T 1206-2013
Preview True-PDF (Reload/Scroll-down if blank)
YY/T 1206-2013: Total cholesterol kit (COD-PAP method)
YY/T 1206-2013
Total cholesterol kit (COD-PAP method)
ICS 11.100
C44
People's Republic of China pharmaceutical industry standards
Total-cholesterol measurement kit (Oxidase)
Issued on. 2013-10-21
2014-10-01 implementation
China Food and Drug Administration released
Foreword
This standard was drafted in accordance with GB/T 1.1-2009 given rules.
Please note that some of the content of this standard may involve patents. The standard release
Institutions do not assume the responsibility to identify these patents.
This standard was proposed by the China Food and Drug Administration.
This standard by the national medical clinical laboratory testing and in vitro diagnostic systems for Standardization Technical Committee (SAC/TC136) centralized.
This standard was drafted. Chinese Academy of Food and Drug test.
The main drafters of this standard. Liu Yan, Sun Nan, Wang Yumei, Zhangchun Tao, noble first.
Total-cholesterol measurement kit (Oxidase)
1 Scope
This standard specifies the total cholesterol assay kit (oxidase) requirements, test methods, labeling and instructions for use, packaging, transport and
Storage.
This standard applies to medical laboratory reagents for quantifying single or double reagent used in liquid-type total-cholesterol measurement kit (oxidation
Enzymatic) quality control.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein
Member. For undated references, the latest edition (including any amendments) applies to this document.
Symbols - Part 1 YY/T 0466.1 medical equipment used with medical device labels, labeling and information. General requirements
3 Requirements
3.1 Appearance
Compatible with the manufacturer's appearance requirements.
3.2 PACKING
Loading amount of the liquid reagent to be less than the labeled amount.
3.3 reagent blank absorbance
At 500nm ~ 550nm wavelength, two-reagent type kit should be less than 0.080, a single reagent type kit should be less than 0.100.
3.4 Linear Interval
Within the linear range specified by the manufacturer, and the theoretical concentration measured concentrations of linear correlation coefficient (r) shall not be less than 0.9900.
3.5 Accuracy
Use standard product has traceability was measured relative deviation of the measured value and the value declared shall be within ± 10.0%.
3.6 Sensitivity Analysis
When test kits given concentration of analyte, change in absorbance (ΔA) shall comply with the manufacturer's given range.
3.7 Precision
3.7.1 within run precision
Intra-assay precision should be less than 4.0%.
Get Quotation: Click YY/T 1206-2013 (Self-service in 1-minute)
Historical versions (Master-website): YY/T 1206-2013
Preview True-PDF (Reload/Scroll-down if blank)
YY/T 1206-2013: Total cholesterol kit (COD-PAP method)
YY/T 1206-2013
Total cholesterol kit (COD-PAP method)
ICS 11.100
C44
People's Republic of China pharmaceutical industry standards
Total-cholesterol measurement kit (Oxidase)
Issued on. 2013-10-21
2014-10-01 implementation
China Food and Drug Administration released
Foreword
This standard was drafted in accordance with GB/T 1.1-2009 given rules.
Please note that some of the content of this standard may involve patents. The standard release
Institutions do not assume the responsibility to identify these patents.
This standard was proposed by the China Food and Drug Administration.
This standard by the national medical clinical laboratory testing and in vitro diagnostic systems for Standardization Technical Committee (SAC/TC136) centralized.
This standard was drafted. Chinese Academy of Food and Drug test.
The main drafters of this standard. Liu Yan, Sun Nan, Wang Yumei, Zhangchun Tao, noble first.
Total-cholesterol measurement kit (Oxidase)
1 Scope
This standard specifies the total cholesterol assay kit (oxidase) requirements, test methods, labeling and instructions for use, packaging, transport and
Storage.
This standard applies to medical laboratory reagents for quantifying single or double reagent used in liquid-type total-cholesterol measurement kit (oxidation
Enzymatic) quality control.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein
Member. For undated references, the latest edition (including any amendments) applies to this document.
Symbols - Part 1 YY/T 0466.1 medical equipment used with medical device labels, labeling and information. General requirements
3 Requirements
3.1 Appearance
Compatible with the manufacturer's appearance requirements.
3.2 PACKING
Loading amount of the liquid reagent to be less than the labeled amount.
3.3 reagent blank absorbance
At 500nm ~ 550nm wavelength, two-reagent type kit should be less than 0.080, a single reagent type kit should be less than 0.100.
3.4 Linear Interval
Within the linear range specified by the manufacturer, and the theoretical concentration measured concentrations of linear correlation coefficient (r) shall not be less than 0.9900.
3.5 Accuracy
Use standard product has traceability was measured relative deviation of the measured value and the value declared shall be within ± 10.0%.
3.6 Sensitivity Analysis
When test kits given concentration of analyte, change in absorbance (ΔA) shall comply with the manufacturer's given range.
3.7 Precision
3.7.1 within run precision
Intra-assay precision should be less than 4.0%.
